Pre-diagnostic anthropometry and survival after colorectal cancer diagnosis in Western European populations

International Journal of Cancer

Volumn 135, Issue 8, 2014, Pages 1949-1960

  Fedirko, Veronika ^a,b   Romieu, Isabelle ^c   Aleksandrova, Krasimira ^d   Pischon, Tobias ^e   Trichopoulos, Dimitrios ^f   Peeters, Petra H ^g,h   Romaguera Bosch, Dora ^h   Bueno De Mesquita, H B ^g,h,i   Dahm, Christina C ^j   Overvad, Kim ^j   Chirlaque, Maria Dolores ^k,l   Johansen, Christoffer ^m,n   Bidstrup, Pernille E ⁿ   Dalton, Susanne O ⁿ   Gunter, Marc J ^h   Wark, Petra A ^h   Norat, Teresa ^h   Halkjær, Jytte ⁿ   Tjønneland, Anne ⁿ   Dik, Vincent K ^g   Siersema, Peter D ^g   Boutron Ruault, Marie Christine ^o,p,q   Dossus, Laure ^o,p,q   Bastide, Nadia ^o,p,q   Kühn, Tilman ^r   Kaaks, Rudolf ^r   Boeing, Heiner ^d   Trichopoulou, Antonia ^s,t   Klinaki, Eleni ^s,t   Katsoulis, Michalis ^s,t   Pala, Valeria ^u   Panico, Salvatore ^v   Tumino, Rosario ^w   Palli, Domenico ^x   Vineis, Paolo ^h,y   Weiderpass, Elisabete ^z,aa,ab,ac   Skeie, Guri ^z   González, Carlos A ^ad   Sánchez, María José ^l,ae   Barricarte, Aurelio ^l,af   Amiano, Pilar ^l,ag   Quiros, J Ramon ^ah   Manjer, Jonas ^ai   Jirström, Karin ^aj   Ljuslinder, Ingrid ^ak   Palmqvist, Richard ^ak   Khaw, Kay Tee ^al   Wareham, Nick ^am   Bradbury, Kathryn E ^an   Stepien, Magdalena ^c   Duarte Salles, Talita ^c   Riboli, Elio ^h   Jenab, Mazda ^c   more..

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^e MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

ⁱ NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^j AARHUS UNIVERSITY   (Denmark)

^k Murcia Regional Health Authority   (Spain)

^l CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^m FINSEN LABORATORY   (Denmark)

ⁿ DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^o INSERM   (France)

^p UNIVERSITÉ PARIS SACLAY   (France)

^q INSTITUT GUSTAVE ROUSSY   (France)

^r GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^s HELLENIC HEALTH FOUNDATION   (Greece)

^t BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^u NATIONAL CANCER INSTITUTE   (Italy)

^v UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^w Cancer Registry and Histopathology Unit   (Italy)

^x CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^y HuGeF Foundation   (Italy)

^z UNIVERSITY OF TROMSØ   (Norway)

^aa CANCER REGISTRY OF NORWAY   (Norway)

^ab KAROLINSKA INSTITUTE   (Sweden)

^ac FOLKHÄLSAN RESEARCH CENTER   (Finland)

^ad CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^ae ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^af INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^ag BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^ah Environmental Health Unit   (Spain)

^ai LUND UNIVERSITY HOSPITAL   (Sweden)

^aj LUND UNIVERSITY   (Sweden)

^ak UMEÅ UNIVERSITY   (Sweden)

^al UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^am UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^an UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

abdominal obesity; body composition; colorectal neoplasms; obesity; survival

Indexed keywords

ABDOMINAL OBESITY; ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; COLORECTAL CANCER; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; TUMOR LOCALIZATION; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WAIST TO HEIGHT RATIO; WESTERN EUROPE;

ABDOMINAL OBESITY; BODY COMPOSITION; COLORECTAL NEOPLASMS; OBESITY; SURVIVAL;

ADENOCARCINOMA; AGED; ANTHROPOMETRY; BODY MASS INDEX; COLORECTAL NEOPLASMS; EUROPE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SEX DISTRIBUTION; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 84905721284     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28841     Document Type: Article

References (48)

1. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008 v2.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer, 2010. Available from: //globocan.iarc.fr. Last accessed on June 30, 2013.
2. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
3. Verdecchia A, Francisci S, Brenner H, et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 2007; 8: 784-96.
4. American Cancer Society. Cancer treatment & survivorship facts and figures 2012-2013. Atlanta, GA: American Cancer Society; 2013. Web site. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/ document/acspc-033876.pdf.
5. Sobin LH, Gospodarowicz MK, Wittekind C,; International Union against Cancer. TNM classification of malignant tumours, 7th edn. Hoboken, NJ: Wiley-Blackwell, 2010.
6. WHO. Obesity and overweight. WHO Media Centre 2013;Fact sheet 311.
7. WCRF/AICR. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: AICR, 2007.
8. Moghaddam AA, Woodward M, Huxley R,. Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev 2007; 16: 2533-47.
9. Parekh N, Chandran U, Bandera EV,. Obesity in cancer survival. Annu Rev Nutr 2012; 32: 311-42.
10. Sinicrope FA, Foster NR, Sargent DJ, et al. Obesity is an independent prognostic variable in colon cancer survivors. Clin Cancer Res 2010; 16: 1884-93.
11. Dignam JJ, Polite BN, Yothers G, et al. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst 2006; 98: 1647-54.
12. Meyerhardt JA, Catalano PJ, Haller DG, et al. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 2003; 98: 484-95.
13. Meyerhardt JA, Niedzwiecki D, Hollis D, et al. Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. J Clin Oncol 2008; 26: 4109-15.
14. Meyerhardt JA, Tepper JE, Niedzwiecki D, et al. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. J Clin Oncol 2004; 22: 648-57.
15. Kuiper JG, Phipps AI, Neuhouser ML, et al. Recreational physical activity, body mass index, and survival in women with colorectal cancer. Cancer Causes Control 2012; 23: 1939-48.
16. Yamamoto N, Fujii S, Sato T, et al. Impact of body mass index and visceral adiposity on outcomes in colorectal cancer. Asia Pacific J Clin Oncol 2012; 8: 337-45.
17. Campbell PT, Newton CC, Dehal AN, et al. Impact of body mass index on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort. J Clin Oncol 2012; 30: 42-52.
18. Doria-Rose VP, Newcomb PA, Morimoto LM, et al. Body mass index and the risk of death following the diagnosis of colorectal cancer in postmenopausal women (United States). Cancer Causes Control 2006; 17: 63-70.
19. Haydon AM, Macinnis RJ, English DR, et al. Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut 2006; 55: 62-7.
20. Prizment AE, Flood A, Anderson KE, et al. Survival of women with colon cancer in relation to precancer anthropometric characteristics: the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 2010; 19: 2229-37.
21. Park SM, Lim MK, Shin SA, et al. Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol 2006; 24: 5017-24.
22. Aleksandrova K, Nimptsch K, Pischon T,. Obesity and colorectal cancer. Front Biosci (Elite Ed) 2013; 5: 61-77.
23. Vongsuvanh R, George J, Qiao L, et al. Visceral adiposity in gastrointestinal and hepatic carcinogenesis. Cancer Lett 2013; 330: 1-10.
24. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002; 5: 1113-24.
25. Bingham S, Riboli E,. Diet and cancer-the European Prospective Investigation into Cancer and Nutrition. Nat Rev Cancer 2004; 4: 206-15.
26. Fedirko V, Riboli E, Tjonneland A, et al. Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations. Cancer Epidemiol Biomarkers Prev 2012; 21: 582-93.
27. Haftenberger M, Lahmann PH, Panico S, et al. Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 2002; 5: 1147-62.
28. Ashwell M, Hsieh SD,. Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int J Food Sci Nutr 2005; 56: 303-7.
29. Norat T, Bingham S, Ferrari P, et al. Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst 2005; 97: 906-16.
30. Boffetta P, Couto E, Wichmann J, et al. Fruit and vegetable intake and overall cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2010; 102: 529-37.
31. WHO Expert Committee on Physical Status: the Use and Interpretation of Anthropometry. Physical status: the use and interpretation of anthropometry: report of a WHO Expert Committee. WHO technical report series. Geneva: World Health Organization, 1995.
32. Alberti KG, Zimmet P, Shaw J,. The metabolic syndrome-a new worldwide definition. Lancet 2005; 366: 1059-62.
33. Durrleman S, Simon R,. Flexible regression models with cubic splines. Stat Med 1989; 8: 551-61.
34. Govindarajulu US, Spiegelman D, Thurston SW, et al. Comparing smoothing techniques in Cox models for exposure-response relationships. Stat Med 2007; 26: 3735-52.
35. Li R, Hertzmark E, Louie M, Chen L, Spiegelman, D., The SAS LGTPHCURV9 Macro. Web site. Accessed on September 1, 2013. http://www.hsph.harvard.edu/ donna-spiegelman/software/lgtphcurv9.
36. Hu FB,. Obesity epidemiology. Oxford, NY: Oxford University Press, 2008.
37. Nur U, Shack LG, Rachet B, et al. Modelling relative survival in the presence of incomplete data: a tutorial. Int J Epidemiol 2010; 39: 118-28.
38. Vimaleswaran KS, Berry DJ, Lu C, et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 2013; 10: e1001383.
39. Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006; 98: 920-31.
40. Grodstein F, Newcomb PA, Stampfer MJ,. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 1999; 106: 574-82.
41. Slattery ML, Potter JD, Curtin K, et al. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res 2001; 61: 126-30.
42. Mandelson MT, Miglioretti D, Newcomb PA, et al. Hormone replacement therapy in relation to survival in women diagnosed with colon cancer. Cancer Causes Control 2003; 14: 979-84.
43. Minoo P, Zlobec I, Peterson M, et al. Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles. Int J Oncol 2010; 37: 707-18.
44. Ogino S, Nosho K, Meyerhardt JA, et al. Cohort study of fatty acid synthase expression and patient survival in colon cancer. J Clin Oncol 2008; 26: 5713-20.
45. Ogino S, Shima K, Nosho K, et al. A cohort study of p27 localization in colon cancer, body mass index, and patient survival. Cancer Epidemiol Biomarkers Prev 2009; 18: 1849-58.
46. Ogino S, Nosho K, Shima K, et al. p21 expression in colon cancer and modifying effects of patient age and body mass index on prognosis. Cancer Epidemiol Biomarkers Prev 2009; 18: 2513-21.
47. Ogino S, Nosho K, Baba Y, et al. A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis. Am J Gastroenterol 2009; 104: 2047-56.
48. Chubak J, Boudreau DM, Wirtz HS, et al. Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival. J Natl Cancer Inst 2013; 105: 1456-62.